Universal Health Services (UHS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net revenues increased 9.6% year-over-year to $4.50 billion for Q1 2026, with strong growth in both acute care and behavioral health segments.
Net income attributable to shareholders rose 10% to $349 million ($5.65 per diluted share), with adjusted EPS up 16.1% year-over-year.
EBITDA net of NCI reached $651.7 million, up from $603.9 million year-over-year.
Announced definitive agreement to acquire Talkspace, a leading virtual behavioral health platform, for $835 million, expected to close in Q3 2026 and be accretive to earnings within 12 months post-closing.
Maintained steady operating performance and cash flow despite challenging seasonal volume trends.
Financial highlights
Operating income rose to $503 million from $455 million year-over-year.
Cash flow from operations was $402 million, up from $360 million year-over-year.
Capital expenditures totaled $217 million in Q1 2026.
Repurchased 675,000 shares for $127 million; $1.3 billion buyback authorization remains.
Debt/total capitalization improved to 38.7% from 40.7% year-over-year.
Outlook and guidance
Reiterated full-year 2026 financial and operating guidance set in February.
Expects earnings ramp through the year to achieve core 5% growth target, with volume and pricing more balanced as seasonal impacts subside.
Guidance includes $75 million pre-tax impact from health insurance exchange (HIX) declines, expected to steepen as the year progresses.
Anticipate annual net benefit from Medicaid supplemental payment programs to decline by $432–$480 million by 2032 due to legislative changes.
Management highlighted risks from changes in Medicaid and Medicare funding, new legislation affecting Medicaid eligibility, and interest rate volatility.
Latest events from Universal Health Services
- Revenue grew, but Q3 earnings fell as 2027 reimbursement headwinds loom.UHS
Q3 2026 - Outpatient and virtual behavioral health expansion, AI adoption, and disciplined capital allocation drive growth.UHS
Morgan Stanley 24th Annual Global Healthcare Conference - Growth driven by new facilities, outpatient behavioral expansion, and Talkspace acquisition amid policy headwinds.UHS
2026 Global Healthcare Conference - Guidance trimmed amid exchange headwinds, with growth focused on outpatient and capacity expansion.UHS
Wells Fargo 21st Annual Healthcare Conference - Strong 2025 results and strategic moves, including the Talkspace deal, drive robust 2026 outlook.UHS
Investor presentation - Q2 2026 net income rose to $358M on 8.3% higher revenues, with major acquisitions and Medicaid risks.UHS
Q2 2026 - Strong 2024 performance, margin recovery, and behavioral growth drive optimism despite policy headwinds.UHS
KeyBanc Annual Healthcare Forum 2025 - Strong 2025 results and 2026 growth outlook, with ongoing investment and managed regulatory risks.UHS
Q4 2025 - Q2 2025 net income up 22% with strong revenue, margin gains, and higher EPS guidance amid Medicaid risks.UHS
Q2 2025 - Q1 2025 net income rose 21% on 6.7% revenue growth, with strong segment performance.UHS
Q1 2025